Compare SENEA & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SENEA | EVO |
|---|---|---|
| Founded | 1949 | 1993 |
| Country | United States | Germany |
| Employees | 6895 | 4553 |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 908.7M | 934.1M |
| IPO Year | N/A | N/A |
| Metric | SENEA | EVO |
|---|---|---|
| Price | $134.86 | $3.16 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 112.3K | 107.4K |
| Earning Date | 06-11-2026 | 04-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1.37 |
| Revenue Next Year | N/A | $10.05 |
| P/E Ratio | $13.21 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $84.66 | $2.31 |
| 52 Week High | $167.52 | $4.80 |
| Indicator | SENEA | EVO |
|---|---|---|
| Relative Strength Index (RSI) | 37.54 | 60.08 |
| Support Level | $129.17 | $2.87 |
| Resistance Level | $148.97 | $3.78 |
| Average True Range (ATR) | 8.30 | 0.11 |
| MACD | -3.55 | 0.06 |
| Stochastic Oscillator | 22.89 | 71.91 |
Seneca Foods Corp is a US-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen, and bottled produce and snack chips. The company's segment includes Vegetable and Fruit/Snack. It generates maximum revenue from the Vegetable segment.
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.